openPR Logo
Press release

Hematological Malignancies Market Is Expected To Profits

08-18-2017 07:59 PM CET | Health & Medicine

Press release from: Transparency Market Research

Hematological Malignancies Market Is Expected To Profits

Global Hematological Malignancies Market: Snapshot

Hematological malignancies, commonly known as hematological cancer, is registering a widespread prevalence across the world. According to the National Cancer Institute, hematological cancer is the fifth most commonly occurring cancer, globally, and is the second prominent reason behind the cancer death in the U.S. Researchers expect the incidence of hematological malignancies to increase further in the coming years, which will result in the growing need for its treatment, impacting the global hematological malignancies market greatly.

View Report @ http://www.transparencymarketresearch.com/hematological-malignancies-market.html

The opportunity in the worldwide market for hematological malignancies, which stood at US$27.4 bn in 2015, is likely to expand at a CAGR of 7.50% during the period from 2016 to 2024 and reach a value of US$51.9 bn by 2024.

The rich product pipeline and the improvement in the reimbursement scenario are likely to drive the growth of the market for hematological malignancies treatment, worldwide, in the near future. Moreover, the rising trend of patent protection is also expected to boost this market considerably in the coming years. 

Demand for Immunotherapy to Remain Strong

Immunotherapy, chemotherapy, and targeted therapy are the three most common treatment methods for hematological malignancies. Among these, immunotherapy led the demand in 2015 with a share of 41.3% in the overall market. The efficiency of immunotherapy, coupled with a lower risk of side effects, has influenced its demand considerably over the last few years.

Going forward, blockbuster drugs, such as Pomalyst, Rituxan, and Revlimid, are impacting the demand for immunotherapy positively and are expected to continue doing do throughout the forecast period, leading to a substantial rise in the immunotherapy segment. Targeted therapy is also anticipated to exhibit promising growth in the near future on account of the massive investments made for the development of targeted therapy products.

Presence of Advanced Healthcare Infrastructure to Ensure Dominance of North America

The worldwide market for hematological malignancies stretches across Asia Pacific, North America, Europe, the Middle East and Africa, and Latin America. Supported by the presence of an advanced medical and healthcare infrastructure, North America market for hematological malignancies has been leading the overall market. The growing prevalence of hematological cancer, the rising awareness level of people, and the availability of modern diagnostic technologies are expected to reflect positively on the demand for hematological malignancies therapeutics in the coming years, ensuring the dominance of this regional market.

Get accurate market forecast and analysis on the Hematological Malignancies Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4580

Apart from this, Asia Pacific is also projected to experience steady growth in the demand for hematological malignancies therapeutics over the next few years. The increasing incidence of blood cancer-related mutation diagnostic cases, rising count of government-supported healthcare programs, and the imminent launch of novel drugs is expected to boost the Asia Pacific market for hematological malignancies during the forecast period. Latin America and the Middle East and Africa are anticipated to offer lucrative growth prospects to market players in the years to come due to the availability of untapped opportunities in abundance.

AbbVie Inc., Bristol-Myers Squibb Co., Celgene Corp., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc., Johnson & Johnson, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. are some of the leading players in the global market for hematological malignancies.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hematological Malignancies Market Is Expected To Profits here

News-ID: 675294 • Views:

More Releases from Transparency Market Research

Dried Potatoes Market to Reach USD 3368.4 Million by 2027, Driven by Convenience Food Demand
Dried Potatoes Market to Reach USD 3368.4 Million by 2027, Driven by Convenience …
The global dried potatoes market is poised for significant growth, with projections indicating a market value of USD 3368.4 million by the end of 2027, reflecting a compound annual growth rate (CAGR) of 3.5% over the forecast period. Volume production is expected to reach 9,675,519 metric tons (MT) by 2027, driven by the rising demand for convenience foods, the expanding food processing industry, and the increasing consumption of processed potatoes. 𝐆𝐞𝐭
Coconut Milk Market to Achieve 6.9% CAGR, Reaching 752,551 MT in Production by 2026
Coconut Milk Market to Achieve 6.9% CAGR, Reaching 752,551 MT in Production by 2 …
The global market for coconut milk products is projected to achieve remarkable growth, with an anticipated market value of US$ 1,508.7 million by the end of 2026. This robust expansion, expected at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period, highlights the increasing consumer preference for plant-based alternatives and the rising popularity of Asian cuisines globally. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=56040 Coconut milk
Dry Natural Gas Market Expected to Reach USD 1.6 Trillion by 2031 with 7.1% CAGR Growth
Dry Natural Gas Market Expected to Reach USD 1.6 Trillion by 2031 with 7.1% CAGR …
The dry natural gas market is poised for significant growth, driven by increasing energy demand, environmental regulations favoring cleaner fuels, and advancements in gas extraction and transportation technologies. The global market, valued at US$ 841.7 billion in 2021, is estimated to grow at a robust compound annual growth rate (CAGR) of 7.1% from 2022 to 2031, reaching US$ 1.6 trillion by the end of 2031. Market Overview: Dry natural gas, composed primarily
Sustainable Marine Fuel Market Projected to Reach USD 218.1 Billion by 2031 with 50.2% CAGR Growth
Sustainable Marine Fuel Market Projected to Reach USD 218.1 Billion by 2031 with …
The sustainable marine fuel market is poised for substantial growth, driven by increasing environmental regulations, a growing focus on decarbonization, and rising demand for cleaner energy sources in the maritime industry. The global industry, valued at US$ 3.8 billion in 2021, is estimated to advance at a remarkable compound annual growth rate (CAGR) of 50.2% from 2022 to 2031, reaching US$ 218.1 billion by the end of 2031. Market Overview: Sustainable marine

All 5 Releases


More Releases for Hematological

Global Hematological Malignancies Biotherapeutics Market
According to a new market research report published by Global Market Estimates, the Global Hematological Malignancies Biotherapeutics Market is projected to grow at a CAGR value of 10.8% from 2022 and 2027. The hematological malignancies biotherapeutics market is driven mainly by the growing incidence of blood cancer, increasing investment in cancer research, growing cancer awareness initiatives, and the growing number of specialized cancer treatment facilities. Browse 151 Market Data Tables and
Advanced Technologies Of Hematological Disorders Market 2017
Albany, NY, 23rd November : Recent research and the current scenario as well as future market potential of "Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need" globally. The hematological disorders therapy area encompasses non-malignant disorders of the blood such as anemia, sickle cell disease, neutropenia and hemophilia. Get PDF for
Hematological Cancers Market 2017 Trends and Review
The Global Hematological Cancers Market Research Report 2017 to 2022 renders deep perception of the key regional market status of the Hematological Cancers Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan. Request for sample of Hematological Cancers Market research report @ https://goo.gl/BeUKBz Split by product type,
Hematological Malignancies Market grows with growing prevalence of hematological …
The global hematological malignancies market is highly competitive in nature and is characterized by a consolidated nature, owing to the presence of a few players holding a large share of the overall market, states a research study by Transparency Market Research. The leading players operating in the global market, including Roche, Celgene, Novartis, and AbbVie are anticipated to remain dominant throughout the forecast period. In order to maintain their position
03-08-2017 | Health & Medicine
TMR
Increasing Incidence of Hematological Cancers is Expected to Boost the Global He …
Hematological cancer, commonly known as hematological malignancy, is a class of cancer that affects the lymph nodes, blood, and bone marrow. It includes numerous forms such as lymphoma, leukemia, and myeloma. Leukemia is a malignancy in which abnormal white blood cells are formed in the bone marrow. Lymphoma is a blood cancer that develops in the lymphatic system. Myeloma is a cancer associated with the plasma of the white blood
01-25-2017 | Health & Medicine
TMR
Rapidly Increasing Hematological Cancer Prevalence among the Population Drives t …
Hematological cancer, commonly known as hematological malignancy, is a class of cancer that affects the lymph nodes, blood, and bone marrow. It includes numerous forms such as lymphoma, leukemia, and myeloma. Leukemia is a malignancy in which abnormal white blood cells are formed in the bone marrow. Lymphoma is a blood cancer that develops in the lymphatic system. Myeloma is a cancer associated with the plasma of the white blood